GATA3 is not a diagnostic biomarker of central nervous system paragangliomas
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:118 |
|---|---|
| Enthalten in: |
Human pathology - 118(2021) vom: 30. Dez., Seite 86-87 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tauziède-Espariat, Arnault [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarkers |
|---|
| Anmerkungen: |
Date Completed 17.12.2021 Date Revised 17.12.2021 published: Print-Electronic CommentOn: Hum Pathol. 2020 Sep;103:72-82. - PMID 32668278 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.humpath.2021.01.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320855430 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320855430 | ||
| 003 | DE-627 | ||
| 005 | 20231225174536.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.humpath.2021.01.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1069.xml |
| 035 | |a (DE-627)NLM320855430 | ||
| 035 | |a (NLM)33524437 | ||
| 035 | |a (PII)S0046-8177(21)00004-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tauziède-Espariat, Arnault |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a GATA3 is not a diagnostic biomarker of central nervous system paragangliomas |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.12.2021 | ||
| 500 | |a Date Revised 17.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Hum Pathol. 2020 Sep;103:72-82. - PMID 32668278 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a GATA3 Transcription Factor |2 NLM | |
| 650 | 7 | |a GATA3 protein, human |2 NLM | |
| 700 | 1 | |a Mehdi, Leïla |e verfasserin |4 aut | |
| 700 | 1 | |a Gareton, Albane |e verfasserin |4 aut | |
| 700 | 1 | |a Laquerrière, Annie |e verfasserin |4 aut | |
| 700 | 1 | |a Adle-Biassette, Homa |e verfasserin |4 aut | |
| 700 | 1 | |a Polivka, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Cazals-Hatem, Dominique |e verfasserin |4 aut | |
| 700 | 1 | |a Varlet, Pascale |e verfasserin |4 aut | |
| 700 | 1 | |a Lechapt-Zalcman, Emmanuèle |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Human pathology |d 1998 |g 118(2021) vom: 30. Dez., Seite 86-87 |w (DE-627)NLM000167614 |x 0046-8177 |7 nnns |
| 773 | 1 | 8 | |g volume:118 |g year:2021 |g day:30 |g month:12 |g pages:86-87 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.humpath.2021.01.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 118 |j 2021 |b 30 |c 12 |h 86-87 | ||